"Cost-Minimization and Budget Impact Analysis of Rituximab SC VS Rituximab IV for Non-Hodgkin’s Lymphoma (NHLs) in Greece"
written by Anatole A. Klyosov, Igor L. Rozhanskii,
published by Journal of Cancer Therapy, Vol.8 No.8, 2017
has been cited by the following article(s)：
SAĞLIK SEKTÖRÜNDE BÜTÇE ETKİ ANALİZİ